Not to Diss Denosumab, but More Data Needed in Breast CancerNot to Diss Denosumab, but More Data Needed in Breast Cancer

Is it time to jump on the bisphosphonate bandwagon? Drs Kathy Miller and George Sledge review the adjuvant use in breast cancer and discuss new data on denosumab to make sense of all the controversy. Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news